CtBP1 Antibodies

Santa Cruz Biotechnology provides a broad selection of CtBP1 monoclonal antibodies for research focused on understanding C-terminal binding protein 1. CtBP1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). C-terminal binding protein 1 functions as a transcriptional co-repressor, regulating gene expression and cellular processes such as differentiation, proliferation, and apoptosis. The involvement of C-terminal binding protein 1 in various signaling pathways makes it a significant focus in cancer and developmental biology research. Studying C-terminal binding protein 1 can reveal new therapeutic possibilities for various diseases. Advanced research techniques using CtBP1 monoclonal antibodies enable detailed examination of protein interactions and cellular localization. Investigating C-terminal binding protein 1 expression patterns helps identify its role in different tissue types and developmental stages. Multiple conjugation options, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), provide flexibility in experimental design. Santa Cruz Biotechnology monoclonal antibodies for CtBP1 research support scientists worldwide in advancing our understanding of cellular regulation and disease mechanisms.